Healthtech Investor Day

Published on 19/06/2019

24-25 juin 2019
Paris, FRANCE

ENYO Pharma team will be present in Paris from the 24th to the 25th of June to assist to the “Healthtech Investor days” a European business event. This will be the opportunity to meet investors and pharma companies.

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US